CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,692 | +103.1% | 144,699 | +133.6% | 0.00% | +100.0% |
| Q2 2023 | $833 | -70.1% | 61,955 | -63.1% | 0.00% | -75.0% |
| Q1 2023 | $2,782 | -98.0% | 167,787 | +758.3% | 0.00% | – |
| Q2 2022 | $137,000 | -94.8% | 19,548 | -93.8% | 0.00% | -100.0% |
| Q1 2022 | $2,613,000 | +119.2% | 315,151 | +79.0% | 0.00% | +200.0% |
| Q4 2021 | $1,192,000 | +631.3% | 176,049 | +471.6% | 0.00% | – |
| Q3 2021 | $163,000 | -83.5% | 30,800 | -89.6% | 0.00% | -100.0% |
| Q4 2020 | $986,000 | +236.5% | 295,292 | +365.8% | 0.00% | 0.0% |
| Q2 2020 | $293,000 | -89.3% | 63,400 | -91.3% | 0.00% | -83.3% |
| Q4 2019 | $2,742,000 | – | 731,259 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |